India Restricts Cough Syrup Sales to Licensed Pharmacies

The Indian central government has updated drug regulations to restrict the sale of cough syrups to licensed medical stores ^[1].

This policy shift targets the widespread misuse of codeine-based medications. By limiting distribution, the government intends to increase public health safety and prevent the illegal diversion of pharmaceutical products into the streets, especially within small villages ^[1], ^[2].

Under the new rules, only pharmacies with valid licenses may sell these syrups ^[1]. This change is designed to eliminate the sale of restricted medicines through unauthorized vendors or general stores in rural regions. The move follows concerns over the accessibility of addictive substances in remote areas where regulatory oversight has historically been lower ^[1].

Enforcement efforts are already underway to identify and seize illegal stockpiles. For example, authorities in the Gonda district of Uttar Pradesh recovered a large shipment of codeine-containing cough syrup on May 31 ^[2]. This seizure highlights the scale of the illicit trade and the necessity of stricter retail controls to break the supply chain of unregulated drugs ^[2].

Government officials have not yet released specific data on the total volume of illegal syrup sales, but the focus remains on the systemic failure of rural distribution points. By mandating that only licensed professionals handle these substances, the state hopes to create a traceable record of sales, and prescriptions ^[1].